Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma
نویسندگان
چکیده
منابع مشابه
A Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملIdentifying Requirements of a Self-care System on Smartphones for Preventing Coronavirus Disease 2019 (COVID-19)
Background: Smartphone applications play a pivotal role in management, providing care and preventing infectious diseases. It also has the potential impact on supportive and self-care. This study aimed to identify the requirements for a smartphones self-care system to prevent corona-virus (COVID-19). Materials & Methods: This was a descriptive study performed in two main stages in 2020. At the ...
متن کاملUnderstanding the 2019-novel Coronavirus (2019-nCoV) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Review Study
Since December 2019, a new coronavirus, called the 2019-novel coronavirus (2019-nCoV), triggers pneumonia outbreak from Wuhan (Huanan seafood market) across China, which now poses major health threats to public health. The Corona Virus Disease-2019 (COVID-19) epidemic by 2019-nCoV is spreading worldwide, and by March 1, 2020, 67 countries, including Iran, have been affected. According to worldw...
متن کاملReview of Therapeutic Candidates for the New Coronavirus disease (COVID19)
Background: COVID-19 infectious disease caused by the sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in late November 2019 in Wuhan, China and has become a worldwide health crisis. The World Health Organization has identified COVID-19 as a public health priority of international concern. This is because the epidemic has become a pandemic and there is no effective antiviral...
متن کاملConvalescent Plasma for Ebola Virus Disease.
n engl j med 374;25 nejm.org June 23, 2016 2498 cizumab according to two definitions of refractoriness.2,3 Regardless of the definition, a lower percentage of patients in the caplacizumab group than in the placebo group had disease that was refractory to treatment, which suggests that caplacizumab might prevent refractory TTP and its associated worse outcomes.1 To clarify, Table 3 of our articl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Thrombosis and Hemostasis
سال: 2020
ISSN: 0094-6176,1098-9064
DOI: 10.1055/s-0040-1712157